CN109206418A - Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method - Google Patents

Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method Download PDF

Info

Publication number
CN109206418A
CN109206418A CN201811342122.3A CN201811342122A CN109206418A CN 109206418 A CN109206418 A CN 109206418A CN 201811342122 A CN201811342122 A CN 201811342122A CN 109206418 A CN109206418 A CN 109206418A
Authority
CN
China
Prior art keywords
furyl
oxadiazoles
dmf
carbon source
oxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201811342122.3A
Other languages
Chinese (zh)
Inventor
及方华
王守才
蒋光彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guilin University of Technology
Original Assignee
Guilin University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilin University of Technology filed Critical Guilin University of Technology
Priority to CN201811342122.3A priority Critical patent/CN109206418A/en
Publication of CN109206418A publication Critical patent/CN109206418A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses one kind with DMF(N, dinethylformamide) be one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method.This method is using 2- furoyl hydrazine as reaction raw materials, with DMF(N, dinethylformamide) it is used as carbon source through carbon cyclization, a step constructs 2-(2- furyl) -1,3,4- oxadiazoles.The method of the present invention synthesizing mean is novel, and reaction condition is mild, meets the demand for development of Green Chemistry.

Description

Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method
Technical field
The invention belongs to the technical fields such as medicine, material, cell biology, and in particular to DMF(N, N- dimethyl methyl Amide) be one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method.
Background technique
1,3,4- oxadiazoles and its derivative are a kind of important physiological activators, have certain anti-inflammatory, antibacterial, resist Cancer, anti-AIDS and coordinate plant growth isoreactivity, certain 1,3,4- furodiazole compounds are also important photoactive substance, have Optical activity can be used as photosensitive macromolecular material applied to electroluminescence instrument.The drug for hypertension tiodazosin listed With the structural unit in Nesapidil all containing 1,3,4- oxadiazoles.Therefore, to the synthesis one of 1,3,4- furodiazole compound It has all been the research hotspot of chemist since straight.Its traditional synthetic method will often use toxic chemical reagent, such as trichlorine oxygen Phosphorus etc..The present invention is with DMF(N, dinethylformamide) it is carbon source, using 2- furoyl hydrazine as reaction raw materials, mild anti- Condition is answered to construct 2-(2- furyl in next step) -1,3,4- oxadiazoles.
The 2-(2- furyl that the present invention synthesizes) -1,3,4- oxadiazoles, structural formula is as follows:
With DMF(N, dinethylformamide) be that one step of carbon source constructs 2-(2- furyl) -1, the method for 3,4- oxadiazoles, New synthesis path is provided for the synthesis of such compound, because of its simple synthetic line, there is huge application value.
Summary of the invention
The object of the present invention is to provide one kind with DMF(N, dinethylformamide) it is that one step of carbon source constructs 2-(2- furans Base) -1,3,4- oxadiazoles method.
Specific steps are as follows:
Raw material is weighed according to following molar ratio, catalyst: oxidant: 2- furoyl hydrazine=0.05 ~ 0.5:1 ~ 4:1;It will be weighed Raw material is placed in reaction vessel, is added solvent n,N-Dimethylformamide (DMF), and carbon cyclization 1 is carried out at 40 ~ 150 DEG C ~ 72 hours;Products therefrom is isolated and purified using column chromatography, and column chromatographic eluate is the mixed liquor of petroleum ether and ethyl acetate, Wherein the volume ratio of petroleum ether and ethyl acetate is 1 ~ 40:1, after isolating and purifying, obtains 2-(2- furyl) -1,3,4- evils two Azoles.
The catalyst is cuprous iodide.
The oxidant is potassium peroxydisulfate.
The method of the present invention has the advantage that
(1) reaction condition is mild.
(2) reaction raw materials are simple and easy to get, green safe.
(3) synthetic route is novel.
Detailed description of the invention
Fig. 1 is the synthetic route chart of the method for the present invention.
Fig. 2 be the embodiment of the present invention 1 obtained in 2-(2- furyl) -1,3,4- oxadiazoles nuclear magnetic resonance spectroscopy.
Fig. 3 be the embodiment of the present invention 1 obtained in 2-(2- furyl) -1,3,4- oxadiazoles carbon-13 nmr spectra.
Specific embodiment
The invention is further described below by specific embodiment.
Embodiment 1:
0.2 mM of 2- furoyl hydrazine is added in the test tube of 25 mL, 0.05 mM of cuprous iodide, potassium peroxydisulfate 0.2 is in the least Mole, DMF(N, dinethylformamide is added) it is used as solvent, it is stirred at 120 DEG C.TLC(thin-layered chromatography) detection reaction After reaction solution is cooled to room temperature, reaction solution filtering, extraction, filtrate decompression revolving removal solvent, then divided by column chromatography From purifying, target product 2-(2- furyl is obtained) -1,3,4- oxadiazoles, it is 3:1 that column chromatographic eluate used, which is volume ratio, Petroleum ether: ethyl acetate mixtures, yield 40%.
The present embodiment structure of title compound is shown in Fig. 2 and Fig. 3.
Comparative example 1:
0.2 mM of the 2- furoyl hydrazine of addition in the test tube of 25 mL, 0.05 mM of cuprous iodide, tert-butyl hydroperoxide 0.2 mM of hydrogen, DMF(N, dinethylformamide is added) it is used as solvent, it is stirred at 120 DEG C.TLC(thin-layered chromatography) Tracing detection does not detect target product.
Comparative example 2:
0.2 mM of the 2- furoyl hydrazine of addition in the test tube of 25 mL, 0.05 mM of cuprous iodide, 0.2 mmoles of silver carbonate You, is added DMF(N, dinethylformamide) it is used as solvent, it is stirred under 120 degrees Celsius.TLC(thin-layered chromatography) tracking inspection It surveys, does not detect target product.
Comparative example 3:
0.2 mM of the 2- furoyl hydrazine of addition in the test tube of 25 mL, 0.05 mM of cuprous iodide, 0.2 mmoles of silver nitrate You, is added DMF(N, dinethylformamide) it is used as solvent, it is stirred under 120 degrees Celsius.TLC(thin-layered chromatography) tracking inspection It surveys, does not detect target product.
Comparative example 4:
0.2 mM of the 2- furoyl hydrazine of addition in the test tube of 25 mL, 0.05 mM of cuprous iodide, 0.2 mmoles of silver oxide You, is added DMF(N, dinethylformamide) it is used as solvent, it is stirred under 120 degrees Celsius.TLC(thin-layered chromatography) tracking inspection It surveys, does not detect target product.
In above-described embodiment, oxidant species have a significant impact reaction effect, and concrete outcome is shown in Table 1.
Table 1
Example Oxidant(oxidant) Yield (%)
Embodiment 1 Potassium peroxydisulfate 40
Comparative example 1 Tert-butyl hydroperoxide 0
Comparative example 2 Silver carbonate 0
Comparative example 3 Silver nitrate 0
Comparative example 4 Silver oxide 0
The present invention has apparent oxidant specificity, can just detect when only using potassium peroxydisulfate as oxidant accordingly Target product;In addition to this, reaction raw materials of the invention are 2- furoyl hydrazine, and raw material is simple and easy to get, the target product of generation 1,3,4- oxadiazoles is then the star molecule of drug field, which is that the synthesis of 1,3,4- furodiazole compounds provides New Research Thinking.

Claims (1)

1. a kind of construct 2-(2- furyl by one step of carbon source of DMF) -1, the method for 3,4- oxadiazoles, it is characterised in that specific step Suddenly are as follows:
Raw material is weighed according to following molar ratio, catalyst: oxidant: 2- furoyl hydrazine=0.05 ~ 0.5:1 ~ 4:1;It will weigh Raw material be placed in reaction vessel, be added solvent n,N-Dimethylformamide, at 40 ~ 150 DEG C carry out carbon cyclization 1 ~ 72 Hour;Products therefrom is isolated and purified using column chromatography, and column chromatographic eluate is the mixed liquor of petroleum ether and ethyl acetate, wherein The volume ratio of petroleum ether and ethyl acetate is 1 ~ 40:1, after isolating and purifying, obtains 2-(2- furyl) -1,3,4- oxadiazoles;
The catalyst is cuprous iodide;
The oxidant is potassium peroxydisulfate.
CN201811342122.3A 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method Withdrawn CN109206418A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811342122.3A CN109206418A (en) 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811342122.3A CN109206418A (en) 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method

Publications (1)

Publication Number Publication Date
CN109206418A true CN109206418A (en) 2019-01-15

Family

ID=64996353

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811342122.3A Withdrawn CN109206418A (en) 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method

Country Status (1)

Country Link
CN (1) CN109206418A (en)

Similar Documents

Publication Publication Date Title
CN109627193B (en) Diaryl azo oxygen compound with anti-tumor effect and synthesis method thereof
Wu et al. Facile synthesis of chromeno [4, 3-b] quinolin-6-ones from unexpected reactions of aryl isocyanides with 4-chloro-2-oxo-2 H-chromene-3-carbaldehyde
CN109206418A (en) Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method
CN109369560A (en) Using DMF as one step of carbon source construct 2-(3- chlorphenyl) -1,3,4- oxadiazoles method
CN109293650A (en) Using DMF as one step of carbon source construct 2-(2- thienyl) -1,3,4- oxadiazoles method
CN109369561A (en) Using DMF as one step of carbon source construct 2-(4- chlorphenyl) -1,3,4- oxadiazoles method
CN109232463A (en) Using DMF as one step of carbon source construct 2-(4- bromophenyl) -1,3,4- oxadiazoles method
CN109336840A (en) Using DMF as one step of carbon source construct 2-(4- fluorophenyl) -1,3,4- oxadiazoles method
CN113072520B (en) C2 substituted 2H-benzothiazole aryl acylation derivative and synthesis method and application thereof
CN109232462A (en) Using DMF as one step of carbon source construct 2-(1- naphthalene) -1,3,4- oxadiazoles method
CN109251185A (en) The method for constructing 2- phenyl -1,3,4- oxadiazoles as one step of carbon source using DMF
CN109336839A (en) Using DMF as one step of carbon source construct 2-(3- tolyl) -1,3,4- oxadiazoles method
CN106397381B (en) 2- alkoxy chromone 9 oxime derivate and the preparation method and application thereof
CN109369559A (en) Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method
CN109232461A (en) Using DMF as one step of carbon source construct 2-(2- tolyl) -1,3,4- oxadiazoles method
CN109336841A (en) Using DMF as one step of carbon source construct 2-(4- nitrobenzophenone) -1,3,4- oxadiazoles method
CN109336837A (en) Using DMF as one step of carbon source construct 2-(4- cyano-phenyl) -1,3,4- oxadiazoles method
CN109336838A (en) The method for constructing 2- p-methylphenyl -1,3,4- oxadiazoles as one step of carbon source using DMF
CN109293594A (en) Using DMF as one step of carbon source construct 2-(4- methoxyphenyl) -1,3,4- oxadiazoles method
CN109206382A (en) Using DMF as one step of carbon source construct 2-(4- tert-butyl-phenyl) -1,3,4- oxadiazoles method
CN109160905A (en) Using DMF as one step of carbon source construct 2-(4- trifluoromethyl) -1,3,4- oxadiazoles method
CN109336880A (en) 2-(3,4- methylenedioxyphenyl are constructed by one step of carbon source of DMF) -1, the method for 3,4- oxadiazoles
CN111635401A (en) Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method
CN115340530B (en) Method for preparing nitrogen-containing heterocyclic derivative and application thereof
CN110105371B (en) Impurities in doladazole bulk drug and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20190115

WW01 Invention patent application withdrawn after publication